# INVOKAMET XR

NDC: 50458-943
Generic name: canagliflozin and metformin hydrochloride
Labeler / Manufacturer: Janssen Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20160920

FDA application: NDA205879

## Active ingredients

- CANAGLIFLOZIN: 150 mg/1
- METFORMIN HYDROCHLORIDE: 1000 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50458-943"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50458-943
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6868666b-c25e-40d1-9d1f-306bbe9390c1